Article Cited by others


Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus

Dave Darshan J

Year : 2011| Volume: 2| Issue : 4 | Page no: 230-235

   This article has been cited by
1 Efficient New Protocols for Converting Primary Amides into Nitriles Initiated by P(NMe2)3, PCl3, or P(OPh)3
Imen Talbi,Mohamed Lotfi Efrit,Soufiane Touil
ACS Omega. 2018; 3(5): 5078
[Pubmed]  [Google Scholar] [DOI]
2 Nephroprotective effect of saxagliptin against gentamicin-induced nephrotoxicity, emphasis on anti-oxidant, anti-inflammatory and anti-apoptic effects
Manar Gamal Helal,Marwa Mohamed Abdel Fattah Zaki,Eman Said
Life Sciences. 2018; 208: 64
[Pubmed]  [Google Scholar] [DOI]
3 Dynamic Compound-Dependent Acoustic Transfer to Investigate Inhibitor Reversibility
Jennifer Nothstein,Elisabeth MacColl,Paul Zuck,Jason Cassaday,Victor N. Uebele,Jeffrey D. Hermes,Michelle F. Homsher
SLAS TECHNOLOGY: Translating Life Sciences Innovation. 2017; 22(5): 485
[Pubmed]  [Google Scholar] [DOI]
4 Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II–Induced Cardiac Diastolic Dysfunction in Male Mice
Scott M Brown,Cassandra E Smith,Alex I Meuth,Maloree Khan,Annayya R Aroor,Hannah M Cleeton,Gerald A Meininger,James R Sowers,Vincent G DeMarco,Bysani Chandrasekar,Ravi Nistala,Shawn B Bender
Endocrinology. 2017; 158(10): 3592
[Pubmed]  [Google Scholar] [DOI]
5 Sulfonamide-1,3,5-triazine–thiazoles: discovery of a novel class of antidiabetic agents via inhibition of DPP-4
Hai-De Gao,Peng Liu,Yang Yang,Fang Gao
RSC Adv.. 2016; 6(86): 83438
[Pubmed]  [Google Scholar] [DOI]
6 Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus
Xiao-Wu Chen,Zhi-Xu He,Zhi-Wei Zhou,Tianxin Yang,Xueji Zhang,Yin-Xue Yang,Wei Duan,Shu-Feng Zhou
Clinical and Experimental Pharmacology and Physiology. 2015; 42(10): 999
[Pubmed]  [Google Scholar] [DOI]
7 Potential of pharmacological modulation of level and activity incretins on diabetes mellitus type 2
A.A. Spasov,N.I. Chepljaeva
Biomeditsinskaya Khimiya. 2015; 61(4): 488
[Pubmed]  [Google Scholar] [DOI]
8 Potential of pharmacological modulation of level and activity of incretins in diabetes mellitus type 2
A. A. Spasov,N. I. Chepljaeva
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 2014; 8(4): 293
[Pubmed]  [Google Scholar] [DOI]
9 Efficacy and safety of add on therapy of bromocriptine with metformin in Indian patients with type 2 diabetes mellitus: A randomized open labeled phase IV clinical trial
Arijit Ghosh,Nilanjan Sengupta,Pranab Sahana,Debasis Giri,Parama Sengupta,Nina Das
Indian Journal of Pharmacology. 2014; 46(1): 24
[Pubmed]  [Google Scholar] [DOI]


Read this article